Dr. Massarelli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Medical Oncology and Therapeutics Research
1500 East Duarte Road
Duarte, CA 91010Phone+1 626-256-4673Fax+1 626-218-8233- Is this information wrong?
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2009 - 2013
Methodist Hospital (Houston)Residency, Internal Medicine, 2007 - 2009
University of Naples Faculty of MedicineClass of 1997
Certifications & Licensure
CA State Medical License 2016 - 2025
TX State Medical License 2012 - 2025- American Board of Internal Medicine Medical Oncology
Clinical Trials
- BATTLE Program: Erlotinib in Previously Treated Subjects With Advanced NSCLC Start of enrollment: 2006 Nov 01
Publications & Presentations
PubMed
- 1 citationsDivarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial.Desai, J., Alonso, G., Kim, S., Cervantes, A., Karasic, T., Medina, L., Shacham-Shmueli, E., Cosman, R., Falcon, A., Gort, E., Guren, T., Massarelli, E., Miller, W., P...> ;Nature Medicine. 2024 Jan 1
- 3 citationsAcquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer.Mohanty, A., Nam, A., Srivastava, S., Jones, J., Lomenick, B., Singhal, S., Guo, L., Cho, H., Li, A., Behal, A., Mirzapoiazova, T., Massarelli, E., Koczywas, M., Arvan...> ;Science Advances. 2023 Oct 13
- 8 citationsHERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer After Epidermal Growth Fac...Helena A Yu, Yasushi Goto, Hidetoshi Hayashi, Enriqueta Felip, James Chih-Hsin Yang, Martin Reck, Kiyotaka Yoh, Se-Hoon Lee, Luis Paz-Ares, Benjamin Besse, Paolo Biron...> ;Journal of Clinical Oncology. 2023 Dec 10
- Join now to see all
Journal Articles
- Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients with Incurable Human Papillomavirus 16–Related CancerErminia Massarelli, William William, Ming Guo, Merrill Kies, Bonnie Glisson, Hai Tran, Faye Johnson, Renata Ferrarotto, Lei Feng, JAMA
Press Mentions
City of Hope Now Enrolling Patients for First-in-Human T Cell Trial for HPV-Associated CancersAugust 15th, 2019
Expert Discusses Treatment Advances in ALK-Positive NSCLCJanuary 9th, 2018- OncLive® to Host State of the Science Summit™: Advanced NonNovember 29th, 2017
- Join now to see all
Hospital Affiliations
City of Hope Comprehensive Cancer CenterDuarte, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
